
Integrating artificial intelligence in drug discovery and early drug development

Cancerappy Participates in New Scientific Publication on AI in Drug Discovery
We’re proud to announce that Cancerappy has contributed to a recently published paper in Biomarker Research titled “Artificial intelligence in drug discovery and early development: current landscape and future opportunities”.
This publication explores how artificial intelligence is reshaping the drug development landscape—from identifying new therapeutic targets to optimizing clinical trial design. It highlights real-world applications and discusses the potential of AI to accelerate innovation, reduce development costs, and bring new therapies to patients faster and more efficiently.
At Cancerappy, we strongly believe in the value of AI to transform oncology drug discovery. Our involvement in this work reflects our commitment to advancing research and supporting the integration of cutting-edge technologies in cancer therapeutics.